The role of basic leucine zipper protein-mediated transcription in physiological and pathological myocardial hypertrophy

Annals of the New York Academy of Sciences

Volumn 1080, Issue , 2006, Pages 97-109

  Kehat, Izhak ^a,b   Hasin, Tal ^a,b   Aronheim, Ami ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Atrium; Hypertrophy; Transcription factors

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CONNEXIN 40; CONNEXIN 43; JUN DIMERIZATION PROTEIN 2; MYOSIN LIGHT CHAIN; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; HEART ATRIUM ENLARGEMENT; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 33845656831     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1380.009     Document Type: Conference Paper

References (51)

1. HO, K.K., J.L. PINSKY, W.B. KANNEL & D. LEVY. 1993. The epidemiology of heart failure: the Framingham Study. J. Am. Coll. Cardiol. 22: 6A-13A.
2. LEVY, D. et al. 2002. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347: 1397-1402.
3. KLEIN, L. et al. 2003. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am. J. Cardiol. 91: 18F-40F.
4. LIANG, Q. & J.D. MOLKENTIN. 2003. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. J. Mol. Cell. Cardiol. 35: 1385-1394.
5. KOMURO, I. & Y. YAZAKI. 1993. Control of cardiac gene expression by mechanical stress. Annu. Rev. Physiol. 55: 55-75.
6. HURST, H.C. 1995. Transcription factors 1: bZIP proteins. Protein Profile 2: 101-168.
7. VINSON, C.R., P.B. SIGLER & S.L. MCKNIGHT. 1989. Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science 246: 911-916.
8. VINSON, C. et al. 2002. Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell. Biol. 22: 6321-6335.
9. SHAULIAN, E. & M. KARIN. 2001. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400.
10. ROCKMAN, H.A. et al. 1991. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 88: 8277-8281.
11. NADRUZ, W. JR., C.B. KOBARG, J. KOBARG & K.G. FRANCHINI. 2004. c-Jun is regulated by combination of enhanced expression and phosphorylation in acute-overloaded rat heart. Am. J. Physiol. Heart Circ. Physiol. 286: H760-H767.
12. CORNELIUS, T., S.R. HOLMER, F.U. MULLER, et al. 1997. Regulation of the rat atrial natriuretic peptide gene after acute imposition of left ventricular pressure overload. Hypertension 30: 1348-1355.
13. FRANTZ, S. et al. 2003. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure. Cardiovasc. Res. 57: 749-756.
14. YOSHIDA, K. et al. 2001. Activation of mitogen-activated protein kinases in the non-ischemic myocardium of an acute myocardial infarction in rats. Jpn. Circ. J. 65: 808-814.
15. TAIMOR, G., K.D. SCHLUTER, P. BEST, et al. 2004. Transcription activator protein 1 mediates alpha- but not beta-adrenergic hypertrophic growth responses in adult cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 286: H2369-H2375.
16. EFERL, R. et al. 1999. Functions of c-Jun in liver and heart development. J. Cell. Biol. 145: 1049-1061.
17. PASSEGUE, E., W. JOCHUM, A. BEHRENS, et al. 2002. JunB can substitute for Jun in mouse development and cell proliferation. Nat. Genet. 30: 158-166.
18. THEPOT, D. et al. 2000. Targeted disruption of the murine junD gene results in multiple defects in male reproductive function. Development 127: 143-153.
19. ANDREUCCI, J.J. et al. 2002. Composition and function of AP-1 transcription complexes during muscle cell differentiation. J. Biol. Chem. 277: 16426-16432.
20. POLLACK, P.S. et al. 1997. Differential expression of c-jun and junD in end-stage human cardiomyopathy. J. Cell. Biochem. 65: 245-253.
21. RICCI, R. et al. 2005. Distinct functions of junD in cardiac hypertrophy and heart failure. Genes Dev. 19: 208-213.
22. VAN WAMEL, A.J., C. RUWHOF, L.J. VAN DER VALK-KOKSHOORN, et al. 2000. Rapid effects of stretched myocardial and vascular cells on gene expression of neonatal rat cardiomyocytes with emphasis on autocrine and paracrine mechanisms. Arch. Biochem. Biophys. 381: 67-73.
23. KOVACIC-MILIVOJEVIC, B. & D.G. GARDNER. 1995. Fra-1, a Fos gene family member that activates atrial natriuretic peptide gene transcription. Hypertension 25: 679-682.
24. GONZALEZ, G.A. & M.R. MONTMINY. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675-680.
25. KWOK, R.P. et al. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370: 223-226.
26. LAMPH, W.W., V.J. DWARKI, R. OFIR, et al. 1990. Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation. Proc. Natl. Acad. Sci. USA 87: 4320-4324.
27. YAMAMOTO, K.K., G.A. GONZALEZ, W.H. BIGGS III & M.R. MONTMINY. 1988. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334: 494-498.
28. FENTZKE, R.C., C.E. KORCARZ, R.M. LANG, et al. 1998. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J. Clin. Invest. 101: 2415-2426.
29. LIU, T., G.P. LI & L.J. LI. 2005. Atrial dilatation and atrial fibrillation: a vicious circle? Med. Hypotheses 65: 410-411.
30. VAZIRI, S.M., M.G. LARSON, E.J. BENJAMIN & D. LEVY. 1994. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 89: 724-730.
31. PSATY, B.M. et al. 1997. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96: 2455-2461.
32. DITTRICH, H.C. et al. 1999. Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am. Heart J. 137: 494-499.
33. TABIBIAZAR, R., R.A. WAGNER, A. LIAO & T. QUERTERMOUS. 2003. Transcriptional profiling of the heart reveals chamber-specific gene expression patterns. Circ. Res. 93: 1193-1201.
34. MAYR, B. & M. MONTMINY. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell. Biol. 2: 599-609.
35. RUDOLPH, D. et al. 1998. Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein. Proc. Natl. Acad. Sci. USA 95: 4481-4486.
36. HUMMLER, E. et al. 1994. Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc. Natl. Acad. Sci. USA 91: 5647-5651.
37. MULLER, F.U. et al. 2005. Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice. J. Biol. Chem. 280: 6906-6914.
38. OKAMOTO, Y. et al. 2001. Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction. Am. J. Pathol. 159: 639-650.
39. HAI, T., C.D. WOLFGANG, D.K. MARSEE, et al. 1999. ATF3 and stress responses. Gene Express. 7: 321-335.
40. YIN, T. et al. 1997. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J. Biol. Chem. 272: 19943-19950.
41. SUBRAMANIAM, A. et al. 1991. Tissue-specific regulation of the alpha-myosin heavy chain gene promotor in transgenic mice. J. Biol. Chem. 266: 24613-24620.
42. KEHAT, I. et al. 2006. Inhibition of basic leucine zipper transcription is a major mediator of atrial dilatation. Cardiovasc. Res. 70: 543-554.
43. JIN, C. et al. 2001. Identification of mouse Jun dimerization protein 2 as a novel repressor of ATF-2. FEBS Lett. 489: 34-41.
44. ARONHEIM, A., E. ZANDI, H. HENNEMANN, et al. 1997. Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol. Cell. Biol. 17: 3094-3102.
45. HAI, T.W., F. LIU, W.J. COUKOS & M.R. GREEN 1989. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3: 2083-2090.
46. HSU, J.C., R. BRAVO & R. TAUB 1992. Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol. Cell. Biol. 12: 4654-4665.
47. LIANG, G., C.D. WOLFGANG, B.P. CHEN, et al. 1996. ATF3 gene. Genomic organization, promotor, and regulation. J. Biol. Chem. 271: 1695-1701.
48. LOWEY, S., G.S. WALLER & K.M. TRYBUS. 1993. Skeletal muscle myosin light chains are essential for physiological speeds of shortening. Nature 365: 454-456.
49. HUANG, C. et al. 2003. Embryonic atrial function is essential for mouse embryogenesis, cardiac morphogenesis and angiogenesis. Development 130: 6111-6119.
50. SANBE, A. et al. 1999. Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J. Biol. Chem. 274: 21085-21094.
51. GRIMM, M. et al. 2005. Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium. Cardiovasc. Res. 65: 211-220.